IR@PKUHSC  > 北京大学第一临床医学院  > 血液内科
学科主题临床医学
High doses of mother′s lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood
Wang, Qian1; Liu, Hongxing2; Zhang, Xian2; Liu, Qian1; Xing, Yanping3; Zhou, Xiaoge4; Tong, Chunrong2; Zhu, Ping1
刊名BLOOD
2010-12-23
DOI10.1182/blood-2010-01-262311
116期:26页:5941-5947
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Hematology
资助者National Ministry of Science and Technology of China ; National Ministry of Science and Technology of China
研究领域[WOS]Hematology
关键词[WOS]BONE-MARROW-TRANSPLANTATION ; VERSUS-HOST-DISEASE ; FETOMATERNAL MICROCHIMERISM ; ADOPTIVE IMMUNOTHERAPY ; FETAL MICROCHIMERISM ; MALIGNANCIES ; RESPONSES ; LEUKEMIA ; INSERTION ; ANTIGENS
英文摘要

Donor lymphocyte infusion is an alternative treatment for Epstein-Barr virus (EBV)-associated lymphoproliferative disorders (LPDs) but with risk of graft-versus-host diseases (GVHDs). According to the fetal-maternal microchimerism tolerance, we assumed that maternal lymphocyte infusion may be effective without causing GVHD. In 54 cases when a child required cytotherapy or hematopoietic stem cell transplantation, we studied the mother for child-mother microchimerism with use of insertion-deletion polymorphisms as allogeneic markers and a combination of nested polymerase chain reaction (PCR) and real-time quantitative PCR. Thirteen mothers were child-microchimerism-positive at the ratio of 10(-5)-10(-3). Among them, 5 children had non-transplant-associated, EBV+ T-cell LPD. In these 5 cases, high doses of human leukocyte antigen-haploidentical maternal peripheral blood mononuclear cells (> 10(8)/kg/infusion) were infused 1-4 times. Symptoms of all 5 patients improved between 3 and 10 days after the infusion; thereafter, 3 cases showed complete remission for 6-18 months without further therapy and 2 had partial remission. During the period of observation, none developed obvious GVHD. By quantitative PCR, in some patients maternal cells were found to be eliminated or decreased after infusions, indicating existence of host-versus-graft reaction. We suggest that high doses of mother′s lymphocyte infusion may be an effective and safe treatment for non-transplant-associated EBV+ T-cell LPD. (Blood. 2010;116(26):5941-5947)

语种英语
所属项目编号2006 DFB 31430
资助者National Ministry of Science and Technology of China ; National Ministry of Science and Technology of China
WOS记录号WOS:000285583400024
引用统计
被引频次:10[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/68166
专题北京大学第一临床医学院_血液内科
作者单位1.Peking Univ First Hosp, Dept Hematol, Beijing 100034, Peoples R China
2.Beijing Daopei Hosp, Hematol Labs, Beijing, Peoples R China
3.Beijing Childrens Hosp, Hematol Ctr, Beijing, Peoples R China
4.Beijing Friendship Hosp, Dept Pathol, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Wang, Qian,Liu, Hongxing,Zhang, Xian,et al. High doses of mother′s lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood[J]. BLOOD,2010,116(26):5941-5947.
APA Wang, Qian.,Liu, Hongxing.,Zhang, Xian.,Liu, Qian.,Xing, Yanping.,...&Zhu, Ping.(2010).High doses of mother′s lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood.BLOOD,116(26),5941-5947.
MLA Wang, Qian,et al."High doses of mother′s lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood".BLOOD 116.26(2010):5941-5947.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Qian]的文章
[Liu, Hongxing]的文章
[Zhang, Xian]的文章
百度学术
百度学术中相似的文章
[Wang, Qian]的文章
[Liu, Hongxing]的文章
[Zhang, Xian]的文章
必应学术
必应学术中相似的文章
[Wang, Qian]的文章
[Liu, Hongxing]的文章
[Zhang, Xian]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。